01 Mar 2015
(MENAFN) UAE’s Julphar registered USD381.1 million revenue in 2014, marking a 5.2 percent increase compared to 2013, Arabian Business reported.
The largest Emirati pharmaceutical company said that sales were motivated by the private market sales which witnessed a 7.5 percent growth with net profit hitting USD63.88 million.
Operational performance also went up with gross profit hitting USD230.86 million, marking a 3.4 percent increase. operating profit reached USD64.91 million.
“2014 was another year of great achievements for Julphar. We are pleased to close the year at USD381.05 million, which shows a remarkable effort from our global sales,” Julphar’s CEO said in a statement.
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
26 Jan 2026
BBK Enhances Autumn Fair 2026 Experience with Customized Rewards and Premium Services
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more